Telepharmacy is delivery of pharmaceutical care via telecommunications to patients in locations where they may not have direct contact with pharmacist. It is an instance of wider phenomenon of telemedicine, as implemented in the field of pharmacy.
Telepharmacy services include drug therapy monitoring, patient counseling, monitoring of formulary compliance with the aid of teleconferencing or videoconferencing.
Telepharmacy services can be delivered at retail pharmacy sites or through hospitals, nursing homes or other medical care facilities.
Rural residents and communities lack easy access to healthcare services often due to geographical and demographical factors.
Telepharmacy holds significant promise as a technology to improve access to pharmaceutical care for people living in rural and remote communities.
Telepharmacy is quickly becoming an integral part of modern pharmacy practice that has the potential to provide quality pharmaceutical services, such as medication management, dispensing, patient counseling, and drug information.
Inherent to the adoption of these practices are legal challenges and pitfalls that need to be addressed. A well-developed system, however, can change the practice of pharmacy that is beneficial to both the rural communities and the hospital or retail pharmacies that deliver these services.
The document discusses telepharmacy, which involves delivering pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It provides an introduction to telepharmacy, outlines its objectives like improving access to healthcare and reducing costs. The document discusses the advantages and disadvantages of telepharmacy, and how it can be implemented. It then covers patient considerations, the process of starting a telepharmacy, license applications, how telepharmacy works, different types of telepharmacy models and concludes that telepharmacy can improve access to pharmaceutical care for rural communities.
This document discusses different types of rate controlled drug delivery systems. It begins by introducing controlled release drug delivery and distinguishing it from sustained release. It then classifies controlled release systems into three main categories: rate programmed, activation modulated, and feedback regulated systems. Within each category it describes several examples of systems, identifying how drug release is controlled in each case. Key factors that can affect controlled release are also listed. The document aims to provide an overview of controlled drug delivery technologies with classifications and examples.
Telepharmacy involves delivering pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It allows pharmacists to actively provide pharmacy services from a distance through technologies like store-and-forward messaging, remote patient monitoring, and mobile care. Telepharmacy can increase access to healthcare for underserved populations, reduce costs, and save travel time for both providers and patients. While it faces challenges like acceptance of the technology and technical constraints, telepharmacy holds promise for improving access to pharmaceutical care for people in rural and remote communities.
Activation modulated drug delivery systemsSonam Gandhi
This document discusses different types of activation modulated drug delivery systems (DDS). It describes DDS that are activated by physical, chemical, or biological means. Some examples of physically activated DDS include osmotic pressure-activated, hydrodynamic pressure-activated, vapour pressure-activated, and mechanically activated systems. Magnetically activated and sonophorosis activated DDS are also mentioned. The document provides details on the mechanisms and equations for rate of drug release for some of these systems. It further discusses iontophoresis-activated and hydration-activated DDS and provides one example for each.
This document discusses three types of triggered drug delivery systems: bioerosion regulated, bioresponsive, and self-regulating. Bioerosion regulated systems use an immobilized enzyme on the surface of a polymer matrix to increase pH and degrade the polymer in the presence of a triggering agent. Bioresponsive systems control drug permeability through a bioresponsive membrane based on local biochemical concentrations. Self-regulating systems use competitive binding within a polymer encapsulated reservoir to activate drug release when triggered by a membrane permeable agent. Examples of insulin delivery are provided for the bioresponsive and self-regulating systems.
Telepharmacy allows for the delivery of pharmaceutical care via telecommunication to patients in remote locations without direct access to a pharmacist. It involves a central pharmacy using audio/video technology to provide clinical services like counseling to remote sites staffed by technicians. The document discusses different telepharmacy models used in various countries and states how it works through the central pharmacy verifying prescriptions and remotely monitoring medication dispensing. While it improves access to care, challenges include ensuring compliance with pharmacy laws and providing continuous care through technology.
Feedback regulated drug delivery systemSurbhi Narang
This document discusses feedback regulated drug delivery systems, which release drugs in response to physiological triggers. It provides 3 examples: 1) Bio-erosion regulated systems where an enzyme triggers polymer degradation and drug release, 2) Bio-responsive systems where a membrane permeability is controlled by biochemical triggers, and 3) Self-regulated systems using reversible binding to competitively release drugs. One approach discussed uses a cationic hydrogel to release an opioid overdose antidote in response to rising carbon dioxide levels from opioid use. Feedback systems aim to better match drug release to physiological needs compared to traditional delivery.
GRDDS-Modulation to GI transit time,Approach to extend GI transit timeRESHMAMOHAN24
This document discusses approaches to extend gastrointestinal transit time by modulating gastric retention through gastroretentive drug delivery systems. It describes the physiology and motility patterns of the GI tract. Common approaches to prolong gastric retention time include high density systems, floating drug delivery systems, and effervescent systems. Floating drug delivery systems can remain buoyant in the stomach for extended periods without affecting gastric emptying.
The document discusses telepharmacy, which involves delivering pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It provides an introduction to telepharmacy, outlines its objectives like improving access to healthcare and reducing costs. The document discusses the advantages and disadvantages of telepharmacy, and how it can be implemented. It then covers patient considerations, the process of starting a telepharmacy, license applications, how telepharmacy works, different types of telepharmacy models and concludes that telepharmacy can improve access to pharmaceutical care for rural communities.
This document discusses different types of rate controlled drug delivery systems. It begins by introducing controlled release drug delivery and distinguishing it from sustained release. It then classifies controlled release systems into three main categories: rate programmed, activation modulated, and feedback regulated systems. Within each category it describes several examples of systems, identifying how drug release is controlled in each case. Key factors that can affect controlled release are also listed. The document aims to provide an overview of controlled drug delivery technologies with classifications and examples.
Telepharmacy involves delivering pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It allows pharmacists to actively provide pharmacy services from a distance through technologies like store-and-forward messaging, remote patient monitoring, and mobile care. Telepharmacy can increase access to healthcare for underserved populations, reduce costs, and save travel time for both providers and patients. While it faces challenges like acceptance of the technology and technical constraints, telepharmacy holds promise for improving access to pharmaceutical care for people in rural and remote communities.
Activation modulated drug delivery systemsSonam Gandhi
This document discusses different types of activation modulated drug delivery systems (DDS). It describes DDS that are activated by physical, chemical, or biological means. Some examples of physically activated DDS include osmotic pressure-activated, hydrodynamic pressure-activated, vapour pressure-activated, and mechanically activated systems. Magnetically activated and sonophorosis activated DDS are also mentioned. The document provides details on the mechanisms and equations for rate of drug release for some of these systems. It further discusses iontophoresis-activated and hydration-activated DDS and provides one example for each.
This document discusses three types of triggered drug delivery systems: bioerosion regulated, bioresponsive, and self-regulating. Bioerosion regulated systems use an immobilized enzyme on the surface of a polymer matrix to increase pH and degrade the polymer in the presence of a triggering agent. Bioresponsive systems control drug permeability through a bioresponsive membrane based on local biochemical concentrations. Self-regulating systems use competitive binding within a polymer encapsulated reservoir to activate drug release when triggered by a membrane permeable agent. Examples of insulin delivery are provided for the bioresponsive and self-regulating systems.
Telepharmacy allows for the delivery of pharmaceutical care via telecommunication to patients in remote locations without direct access to a pharmacist. It involves a central pharmacy using audio/video technology to provide clinical services like counseling to remote sites staffed by technicians. The document discusses different telepharmacy models used in various countries and states how it works through the central pharmacy verifying prescriptions and remotely monitoring medication dispensing. While it improves access to care, challenges include ensuring compliance with pharmacy laws and providing continuous care through technology.
Feedback regulated drug delivery systemSurbhi Narang
This document discusses feedback regulated drug delivery systems, which release drugs in response to physiological triggers. It provides 3 examples: 1) Bio-erosion regulated systems where an enzyme triggers polymer degradation and drug release, 2) Bio-responsive systems where a membrane permeability is controlled by biochemical triggers, and 3) Self-regulated systems using reversible binding to competitively release drugs. One approach discussed uses a cationic hydrogel to release an opioid overdose antidote in response to rising carbon dioxide levels from opioid use. Feedback systems aim to better match drug release to physiological needs compared to traditional delivery.
GRDDS-Modulation to GI transit time,Approach to extend GI transit timeRESHMAMOHAN24
This document discusses approaches to extend gastrointestinal transit time by modulating gastric retention through gastroretentive drug delivery systems. It describes the physiology and motility patterns of the GI tract. Common approaches to prolong gastric retention time include high density systems, floating drug delivery systems, and effervescent systems. Floating drug delivery systems can remain buoyant in the stomach for extended periods without affecting gastric emptying.
This document discusses mechanically activated drug delivery devices, specifically metered dose inhalers, dry powder inhalers, and nebulizers. Metered dose inhalers precisely deliver medication in aerosol form via inhalation. Dry powder inhalers use breath activation to deliver dry powder medication. Nebulizers convert liquid medication into an inhalable mist using compressed air or ultrasonic power. Each device type has advantages like precision or not requiring compressed gas, but also disadvantages such as potential waste or lower efficiency.
Description about a type of activation modulated drug delivery system, which a type of control drug delivery system.
Also, give a detailed description about each subclassification.
CrDDS is one which delivers the drug at a predetermined rate, for locally or systematically, for a prolong period of time.
This document provides an introduction to sustained release and controlled release drug formulations. It defines sustained release as slowly releasing a drug over 8-12 hours, while controlled release delivers a drug at a predetermined rate for a specified time period. Some key advantages of these formulations are improved patient compliance, better drug utilization, and decreased side effects. Physicochemical drug properties like solubility, permeability and stability can impact whether a drug is suitable for these delivery systems. The document discusses various approaches for sustained and controlled release based on these physicochemical factors.
This document discusses mechanical and pH activated drug delivery systems. Mechanical systems include metered dose inhalers, dry powder inhalers, and nebulizers which deliver drugs through physical activation. pH activated systems target drug delivery based on pH ranges in different body regions. They are classified as hydrogels, nanoparticles, microspheres, and microgels which protect drugs from gastric conditions and release them in the intestines based on pH changes. The advantages are site-specific delivery and protection of drugs, while disadvantages include non-biodegradability of polymers and lack of specificity between similar pH regions.
This document discusses modern pharmaceutics and preformulation concepts. It begins with an introduction to preformulation, which involves investigating a drug's physical and chemical properties alone and with excipients. This information guides dosage form development. The document then discusses drug-excipient interactions and compatibility testing methods. It also covers topics like solid dispersions, emulsions, suspensions, and parenteral product formulation and testing requirements.
Hippa new requirement to clinical study processesKavya S
The document discusses the Health Insurance Portability and Accountability Act (HIPAA) and its implications for clinical research. HIPAA establishes privacy rules to protect patients' protected health information (PHI). It requires authorization from patients for disclosure of PHI for research purposes. Institutional review boards can grant waivers allowing use of PHI without individual authorization. Researchers must comply with HIPAA requirements regarding accounting for and reporting on disclosures of PHI. Covered entities like physicians can disclose limited PHI to researchers but must protect PHI provided.
This document discusses telepharmacy, which is the delivery of pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It can involve a small rural site being connected to an urban pharmacy center to provide services like dispensing, counseling, and clinical monitoring remotely. Telepharmacy aims to improve access to pharmacy services in rural areas facing pharmacist shortages by allowing one pharmacist to oversee multiple remote sites. It discusses the implementation, technologies used, and different types of telepharmacy including inpatient order review, remote dispensing, IV admixture, and remote counseling. The benefits are seen as improved access to care, patient satisfaction, and economic advantages over opening new pharmacies.
This presentation includes introduction, physiology of GIT, factors affecting GRDDS, Advantages and disadvantages, approaches to GRDDS and their mechanism, some of the marketed products using GRDDS mechanism.
This document discusses single shot vaccines that can provide protection against multiple diseases with only one injection. It describes how single shot vaccines work by combining an antigen, adjuvant, and microsphere component that encapsulates and slowly releases the antigen. Key factors in developing these vaccines include controlling particle size, optimizing encapsulation efficiency, and regulating antigen release from the biodegradable microspheres. Single shot vaccines offer advantages like improved patient compliance and lower costs compared to traditional multi-dose vaccines.
Telepharmacy allows pharmacists to provide care to remote areas through telecommunications. It involves pharmacists remotely reviewing prescriptions, monitoring drug therapy, and counseling patients via videoconferencing from an urban center connected to rural clinics. This improves access to healthcare in isolated communities by allowing one pharmacist to serve multiple remote sites, reducing costs. Studies show telepharmacy can decrease medication errors and adverse drug events by increasing pharmacist oversight. However, regulations regarding the pharmacist's physical location and role need to be addressed for telepharmacy to fully address shortages in rural pharmacy services.
This topic is part of Drug Delivery System of M. Pharm pharmaceutics 1st SEM .
Telepharmacy means how we can approach a pharmacist by internet without physical presence of a pharmacist and how we can take care by taking advice from them.
This document discusses different types of controlled drug delivery systems. It classifies systems as rate preprogrammed, activation modulated, or feedback regulated. Rate preprogrammed systems are further broken down into polymer membrane permeation controlled systems, polymer matrix diffusion controlled systems, and microreservoir partition controlled systems. The key aspects and release kinetics of each system type are described through examples. Factors that influence drug release rates from these systems include membrane thickness, drug solubility, diffusivity, and partitioning coefficients.
Telepharmacy allows pharmacists to provide pharmaceutical services to remote areas using telecommunications technology. It aims to improve access to healthcare in underserved populations by allowing a single pharmacist to supervise multiple small clinics and hospitals remotely. The main types of telepharmacy are remote order review, remote dispensing, IV admixture preparation, and remote patient counseling. While it provides economic and access benefits, challenges include additional costs and operational difficulties of the remote workflow model. Telepharmacy has potential to address pharmacist shortages but also requires addressing legal issues regarding the remote practice of pharmacy.
Telepharmacy involves the delivery of pharmaceutical care via telecommunications to patients who do not have direct contact with a pharmacist. It allows remote dispensing of medications and pharmacist monitoring of drug therapy. While telepharmacy improves access to care in remote areas by reducing travel requirements, it faces challenges in implementation due to lack of uniform regulations, technological limitations in rural areas, and changes to workflow. When actively involving pharmacists, telepharmacy can enhance quality of care by improving medication management and reducing errors.
This presentation includes the detail information about the physics of tablet compression and compaction, Compression, Effect of friction, distribution of forces, compaction profiles,solubility.
Telepharmacy By Nikita Sahu (P'ceutics).pptxNikitaSahu39
Telepharmacy allows patients in remote areas to access pharmaceutical care services through telecommunications and information technologies without direct contact with a pharmacist. It has several benefits like increasing access to healthcare in rural areas, reducing costs, and improving patient satisfaction. However, it also faces some challenges like difficulties in operations due to limited infrastructure in rural areas, reluctance of elderly patients to use technology, and ensuring security of patient information transmitted online. Regulations also need to be updated to adequately address telepharmacy operations and technologies.
This document discusses mechanically activated drug delivery devices, specifically metered dose inhalers, dry powder inhalers, and nebulizers. Metered dose inhalers precisely deliver medication in aerosol form via inhalation. Dry powder inhalers use breath activation to deliver dry powder medication. Nebulizers convert liquid medication into an inhalable mist using compressed air or ultrasonic power. Each device type has advantages like precision or not requiring compressed gas, but also disadvantages such as potential waste or lower efficiency.
Description about a type of activation modulated drug delivery system, which a type of control drug delivery system.
Also, give a detailed description about each subclassification.
CrDDS is one which delivers the drug at a predetermined rate, for locally or systematically, for a prolong period of time.
This document provides an introduction to sustained release and controlled release drug formulations. It defines sustained release as slowly releasing a drug over 8-12 hours, while controlled release delivers a drug at a predetermined rate for a specified time period. Some key advantages of these formulations are improved patient compliance, better drug utilization, and decreased side effects. Physicochemical drug properties like solubility, permeability and stability can impact whether a drug is suitable for these delivery systems. The document discusses various approaches for sustained and controlled release based on these physicochemical factors.
This document discusses mechanical and pH activated drug delivery systems. Mechanical systems include metered dose inhalers, dry powder inhalers, and nebulizers which deliver drugs through physical activation. pH activated systems target drug delivery based on pH ranges in different body regions. They are classified as hydrogels, nanoparticles, microspheres, and microgels which protect drugs from gastric conditions and release them in the intestines based on pH changes. The advantages are site-specific delivery and protection of drugs, while disadvantages include non-biodegradability of polymers and lack of specificity between similar pH regions.
This document discusses modern pharmaceutics and preformulation concepts. It begins with an introduction to preformulation, which involves investigating a drug's physical and chemical properties alone and with excipients. This information guides dosage form development. The document then discusses drug-excipient interactions and compatibility testing methods. It also covers topics like solid dispersions, emulsions, suspensions, and parenteral product formulation and testing requirements.
Hippa new requirement to clinical study processesKavya S
The document discusses the Health Insurance Portability and Accountability Act (HIPAA) and its implications for clinical research. HIPAA establishes privacy rules to protect patients' protected health information (PHI). It requires authorization from patients for disclosure of PHI for research purposes. Institutional review boards can grant waivers allowing use of PHI without individual authorization. Researchers must comply with HIPAA requirements regarding accounting for and reporting on disclosures of PHI. Covered entities like physicians can disclose limited PHI to researchers but must protect PHI provided.
This document discusses telepharmacy, which is the delivery of pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It can involve a small rural site being connected to an urban pharmacy center to provide services like dispensing, counseling, and clinical monitoring remotely. Telepharmacy aims to improve access to pharmacy services in rural areas facing pharmacist shortages by allowing one pharmacist to oversee multiple remote sites. It discusses the implementation, technologies used, and different types of telepharmacy including inpatient order review, remote dispensing, IV admixture, and remote counseling. The benefits are seen as improved access to care, patient satisfaction, and economic advantages over opening new pharmacies.
This presentation includes introduction, physiology of GIT, factors affecting GRDDS, Advantages and disadvantages, approaches to GRDDS and their mechanism, some of the marketed products using GRDDS mechanism.
This document discusses single shot vaccines that can provide protection against multiple diseases with only one injection. It describes how single shot vaccines work by combining an antigen, adjuvant, and microsphere component that encapsulates and slowly releases the antigen. Key factors in developing these vaccines include controlling particle size, optimizing encapsulation efficiency, and regulating antigen release from the biodegradable microspheres. Single shot vaccines offer advantages like improved patient compliance and lower costs compared to traditional multi-dose vaccines.
Telepharmacy allows pharmacists to provide care to remote areas through telecommunications. It involves pharmacists remotely reviewing prescriptions, monitoring drug therapy, and counseling patients via videoconferencing from an urban center connected to rural clinics. This improves access to healthcare in isolated communities by allowing one pharmacist to serve multiple remote sites, reducing costs. Studies show telepharmacy can decrease medication errors and adverse drug events by increasing pharmacist oversight. However, regulations regarding the pharmacist's physical location and role need to be addressed for telepharmacy to fully address shortages in rural pharmacy services.
This topic is part of Drug Delivery System of M. Pharm pharmaceutics 1st SEM .
Telepharmacy means how we can approach a pharmacist by internet without physical presence of a pharmacist and how we can take care by taking advice from them.
This document discusses different types of controlled drug delivery systems. It classifies systems as rate preprogrammed, activation modulated, or feedback regulated. Rate preprogrammed systems are further broken down into polymer membrane permeation controlled systems, polymer matrix diffusion controlled systems, and microreservoir partition controlled systems. The key aspects and release kinetics of each system type are described through examples. Factors that influence drug release rates from these systems include membrane thickness, drug solubility, diffusivity, and partitioning coefficients.
Telepharmacy allows pharmacists to provide pharmaceutical services to remote areas using telecommunications technology. It aims to improve access to healthcare in underserved populations by allowing a single pharmacist to supervise multiple small clinics and hospitals remotely. The main types of telepharmacy are remote order review, remote dispensing, IV admixture preparation, and remote patient counseling. While it provides economic and access benefits, challenges include additional costs and operational difficulties of the remote workflow model. Telepharmacy has potential to address pharmacist shortages but also requires addressing legal issues regarding the remote practice of pharmacy.
Telepharmacy involves the delivery of pharmaceutical care via telecommunications to patients who do not have direct contact with a pharmacist. It allows remote dispensing of medications and pharmacist monitoring of drug therapy. While telepharmacy improves access to care in remote areas by reducing travel requirements, it faces challenges in implementation due to lack of uniform regulations, technological limitations in rural areas, and changes to workflow. When actively involving pharmacists, telepharmacy can enhance quality of care by improving medication management and reducing errors.
This presentation includes the detail information about the physics of tablet compression and compaction, Compression, Effect of friction, distribution of forces, compaction profiles,solubility.
Telepharmacy By Nikita Sahu (P'ceutics).pptxNikitaSahu39
Telepharmacy allows patients in remote areas to access pharmaceutical care services through telecommunications and information technologies without direct contact with a pharmacist. It has several benefits like increasing access to healthcare in rural areas, reducing costs, and improving patient satisfaction. However, it also faces some challenges like difficulties in operations due to limited infrastructure in rural areas, reluctance of elderly patients to use technology, and ensuring security of patient information transmitted online. Regulations also need to be updated to adequately address telepharmacy operations and technologies.
Telepharmacy enables the provision of pharmaceutical services through telecommunication technologies between remote sites and central pharmacies. A qualified pharmacist at the central location can review prescriptions, dispense medications, provide counseling, and monitor patients located far away. Telepharmacy improves access to healthcare in rural areas by allowing pharmacist services without travel. However, regulatory issues and operational challenges like technological limitations and increased workload need to be addressed for telepharmacy to be implemented effectively.
Tele pharmacy is the delivery of pharmaceutical care via telecommunications to patients have in locations where they may not have direct contact with a pharmacist.
Telecommunication systems applied to telemedicineShazia Iqbal
Telemedicine allows health care professionals to evaluate, diagnose and treat patients at a distance using telecommunications technology.
The approach has been through a striking evolution in the last decade and it is becoming an increasingly important.
(Glossary of Telemedicine and eHealth)· Teleconsultation Cons.docxAASTHA76
(Glossary of Telemedicine and eHealth)
· Teleconsultation: Consultation between a provider and specialist at distance using either store and forward telemedicine or real time videoconferencing.
· Telehealth and Telemedicine: Telemedicine is the use of medical information exchanged from one site to another via electronic communications to improve patients' health status. Closely associated with telemedicine is the term "telehealth," which is often used to encompass a broader definition of remote healthcare that does not always involve clinical services. Videoconferencing, transmission of still images, e-health including patient portals, remote monitoring of vital signs, continuing medical education and nursing call centers are all considered part of telemedicine and telehealth. Telemedicine is not a separate medical specialty. Products and services related to telemedicine are often part of a larger investment by health care institutions in either information technology or the delivery of clinical care. Even in the reimbursement fee structure, there is usually no distinction made between services provided on site and those provided through telemedicine and often no separate coding required for billing of remote services. Telemedicine encompasses different types of programs and services provided for the patient. Each component involves different providers and consumers.
· TeleICU: TeleICU is a collaborative, interprofessional model focusing on the care of critically ill patients using telehealth technologies.
· Telemonitoring: The process of using audio, video, and other telecommunications and electronic information processing technologies to monitor the health status of a patient from a distance.
· Telemonitoring: The process of using audio, video, and other telecommunications and electronic information processing technologies to monitor the health status of a patient from a distance.
· Clinical Decision Support System (CCDS): Systems (usually electronically based and interactive) that provide clinicians, staff, patients, and other individuals with knowledge and person-specific information, intelligently filtered and presented at appropriate times, to enhance health and health care. (http://healthit.ahrq.gov/images/jun09cdsreview/09_0069_ef.html)
· e-Prescribing: The electronic generation, transmission and filling of a medical prescription, as opposed to traditional paper and faxed prescriptions. E-prescribing allows for qualified healthcare personnel to transmit a new prescription or renewal authorization to a community or mail-order pharmacy.
· Home Health Care and Remote Monitoring Systems: Care provided to individuals and families in their place of residence for promoting, maintaining, or restoring health or for minimizing the effects of disability and illness, including terminal illness. In the Medicare Current Beneficiary Survey and Medicare claims and enrollment data, home health care refers to home visits by professionals including nu.
Telemedicine refers to providing healthcare services remotely using telecommunications technology. It allows patients to consult with providers without being physically present through video calls, phone calls, texting, and online portals. Some key uses of telemedicine include consultations, remote patient monitoring, mental health services, and prescription refills. Telemedicine provides benefits like improved access to care, reduced costs and travel time, and potential for earlier diagnosis. However, it also faces challenges such as insufficient infrastructure, privacy/security concerns, regulatory barriers, and reimbursement issues. Overall, telemedicine can expand markets, lower costs, improve efficiency and patient satisfaction, and generate new revenue streams for healthcare businesses.
Telepharmacy is the delivery of pharmaceutical care via telecommunications to patients in locations where they may not have direct contact with a pharmacist.
seminar presentation
Telemedicine is a collection of means or methods for enhancing health care, public health and health education delivery and support using telecommunications technologies. With more than 95% of adults, and 100% of young adults between the age of 18-29 owning a cell phone in the United States, a technology-based health intervention can be available to hard-to-reach populations or underserved areas.
Panelists will engage a rich dialogue and showcase innovative and effective ways to create prevention programs for HIV and STDs using the potential telehealth can offer, specifically with linking young people to HIV pre-exposure prophylaxis, or PrEP. This plenary brings together leaders in the field of HIV prevention, research and policy along with private organizations and companies that are currently active on the field of biomedical prevention.
Informatics And Telehealth In Rural Medicines TedEx Video Analysis.pdfbkbk37
Telehealth tools like videoconferencing and mobile health technologies can improve patient outcomes in rural areas by improving access to care. Nurse practitioners trained in emergency telehealth can bridge healthcare gaps for remote populations. A tele-emergency program connecting rural hospitals to an academic medical center found cardiac arrest survival rates comparable to the urban hospital, showing telehealth can improve rural emergency care quality. However, for telehealth programs to be widely adopted, they must also prove financially sustainable through benefits like reduced transfers and staffing costs.
Telemedicine has moved to the forefront of healthcare, opening up opportunities for both practices and their patients. To help unpack some of the enormous amounts of new information, This presentation focuses on:
- Relaxing of Regulatory Issues
- How Telemedicine Can Help Your Practice
- Challenges
- The Future of Telemedicine
Chapter 8Telehealth and Applications for Delivering Care at a JinElias52
Here are two potential ethical issues that could arise with telehealth delivered nursing care:
1. Privacy and confidentiality. When providing care via telehealth technologies like video conferencing, there is a risk of private health information being inadvertently disclosed if the virtual session is not properly secured. Nurses must take steps to ensure telehealth encounters occur in a private setting where the patient cannot be overheard or the screen viewed by unauthorized individuals. Appropriate security measures and informed consent about potential privacy risks are important.
2. Informed consent. It can be more difficult to fully explain to patients the nature and limitations of telehealth care compared to traditional in-person visits. Patients may not understand the technologies being used or realize certain physical exams cannot
This is a Telemedicine report I was asked to put together for some various hospitals in Michigan looking to add this technology and was asked by HIMSS members to publish.
Telepharmacy involves the delivery of pharmacy services via telecommunications to patients who do not have direct contact with a pharmacist. It allows remote dispensing of medications and can provide services like drug therapy monitoring and patient counseling. Telepharmacy is commonly used in small hospitals, pharmacies, or clinics in isolated rural areas that are connected to an urban pharmacy with greater pharmacist access. It ensures patients in remote areas have access to medications and pharmacist care.
1 Final Report Assignment - HCI499 INTRODUCTION .docxtarifarmarie
1
Final Report Assignment - HCI499
INTRODUCTION
The health information systems adoption is one of the most effective methods used to
alleviate the widening health care demand and supply gap. The purpose of this report
assignment is to identify and evaluate the current health care delivery system in your
training hospital. This evaluation should lead you to propose a healthcare system or
application and explain why this health system or application should be implemented
in your selected hospital.
Your Description of the Proposed System or (Health Application) should include:
1. The organization overview
2. Proposed System or Application, Its Features and Benefits
3. Its Challenges and Successful Factors
4. Tangible Values in Terms of Money
5. Tangible Values in Terms of Clinical Improvement
6. Patient Values
Submission:
You should submit as a .pdf document to the blackboard on the deadline. late submissions will
not be accepted after the deadline.
Instructions:
• This report should indicate that you’ve fulfilled the internship objectives
• Plagiarism is strictly not accepted in any form
• Overall Word limit = 300 to 600 words
• Well Referenced
• Font size = 12
• Font style = Times New Roman
• Double- Space
Overview about training report:
Training Report for health informatics specialist at Hospital, which has health information system and electronic health. Check the other the attached files for topic. Pick one topic from dawn write about challenge and success topic.
no plagiarism. Write by your own words not copy /paste
300 to 600 words.
(Glossary of Telemedicine and eHealth)
· Teleconsultation: Consultation between a provider and specialist at distance using either store and forward telemedicine or real time videoconferencing.
· Telehealth and Telemedicine: Telemedicine is the use of medical information exchanged from one site to another via electronic communications to improve patients' health status. Closely associated with telemedicine is the term "telehealth," which is often used to encompass a broader definition of remote healthcare that does not always involve clinical services. Videoconferencing, transmission of still images, e-health including patient portals, remote monitoring of vital signs, continuing medical education and nursing call centers are all considered part of telemedicine and telehealth. Telemedicine is not a separate medical specialty. Products and services related to telemedicine are often part of a larger investment by health care institutions in either information technology or the delivery of clinical care. Even in the reimbursement fee structure, there is usually no distinction made between services provided on site and those provided through telemedicine and often no separate coding required for billing of remote services. Telemedicine encompasses different types of programs and services provided for the patient. Each component involves differe.
WAL_HUMN1020_03_A_EN-CC.mp4Chapter 8 Telehealth and Applicat.docxcelenarouzie
WAL_HUMN1020_03_A_EN-CC.mp4
Chapter 8 Telehealth and Applications for Delivering Care at a Distance
Loretta Schlachta-Fairchild
Mitra Rocca
Vicky Elfrink Cordi
Andrea Haught
Diane Castelli
Kathleen MacMahon
Dianna Vice-Pasch
Daniel A. Nagel
Antonia Arnaert
Growth in telehealth could result in a future where access to healthcare is not limited by geographic region, time, or availability of skilled healthcare professionals.
Objectives
At the completion of this chapter the reader will be prepared to:
1.Discuss the historical milestones and leading organizations in the development of telehealth
2.Explain the two overarching types of telehealth technology interactions and provide examples of telehealth technologies for each type
3.Describe the clinical practice considerations for telehealth-delivered care for health professionals
4.Analyze operational and organizational success factors and barriers for telehealth within healthcare organizations
5.Discuss practice and policy considerations for health professionals, including competency, licensure and interstate practice, malpractice, and reimbursement for telehealth
6.Describe the use of telehealth to enable self-care in consumer informatics
7.Discuss future trends in telehealth
Key Terms
Digital literacy, 141
Telehealth, 125
Telehealth competency, 131
Telemedicine, 126
Telenursing, 126
uHealth, 141
Abstract
Rapid advances in technology development and telehealth adoption are opening new opportunities for healthcare providers to leverage these technologies in achieving improved patient outcomes. Telehealth provides access to care and the ability to export clinical expertise to those patients who require care, regardless of the patients' geographic location. This chapter presents telehealth technologies and programs as well as telehealth practice considerations such as licensure and malpractice challenges. As telehealth advances, healthcare providers will require competencies and knowledge to incorporate safe and effective clinical practice using telehealth technologies into their daily workflow.
Introduction
Rapid advances in technology development and telehealth adoption are opening new opportunities for healthcare providers to leverage these technologies in achieving improved patient outcomes. Before we discuss these technologies and outcomes, it is important to explore the definitions of telehealth-related terminology.
Telehealth encompasses a broad definition of telecommunications and information technology–enabled healthcare services and technologies. Often used interchangeably with the terms telemedicine, ehealth, or mhealth (mobile health), telehealth is “the use of electronic information and telecommunications technologies to support long-distance clinical health care, patient and professional health-related education, public health, and health administration.”1 Telehealth is being used in this text to encompass all of these other terms. Telemedicine is .
Chapter 8 Telehealth and Applications for Delivering Care at a Dis.docxchristinemaritza
This chapter discusses telehealth and its potential to improve access to healthcare regardless of location. It defines key telehealth terms and describes the historical development of telehealth. Examples are provided of different telehealth programs demonstrating the range of services. The chapter outlines considerations for clinical practice and organizational implementation of telehealth. It also discusses regulatory and policy issues, future trends, and technologies used in telehealth.
This document summarizes a presentation on telemedicine given by Dr. David Voran to the Southwest Clinical Society in Kansas City on October 29-31, 2015. The presentation reviewed the current status and growth of telemedicine globally and locally, including expanding specialty telemedicine, provider consultations, and retail clinics. It also examined new technologies like mobile telemedicine applications and devices. Dr. Voran projected that telemedicine adoption will continue growing as technologies advance, regulations change to support reimbursement, and its use becomes more integrated into daily healthcare through patient portals, remote monitoring devices, and direct-to-consumer services.
The COVID-19 pandemic continues to present challenges to healthcare practices. This presentation covers the reinstatement of elective surgeries in a few states, the greater adoption of remote tracking, and new developments with the FCC’s Telehealth Program.
It also goes over the technology CareOptimize has developed to help streamline COVID-19 monitoring and reporting, its genesis, and how this utility can help your practice post-pandemic.
Jennifer Schaus and Associates hosts a complimentary webinar series on The FAR in 2024. Join the webinars on Wednesdays and Fridays at noon, eastern.
Recordings are on YouTube and the company website.
https://www.youtube.com/@jenniferschaus/videos
Working with data is a challenge for many organizations. Nonprofits in particular may need to collect and analyze sensitive, incomplete, and/or biased historical data about people. In this talk, Dr. Cori Faklaris of UNC Charlotte provides an overview of current AI capabilities and weaknesses to consider when integrating current AI technologies into the data workflow. The talk is organized around three takeaways: (1) For better or sometimes worse, AI provides you with “infinite interns.” (2) Give people permission & guardrails to learn what works with these “interns” and what doesn’t. (3) Create a roadmap for adding in more AI to assist nonprofit work, along with strategies for bias mitigation.
Combined Illegal, Unregulated and Unreported (IUU) Vessel List.Christina Parmionova
The best available, up-to-date information on all fishing and related vessels that appear on the illegal, unregulated, and unreported (IUU) fishing vessel lists published by Regional Fisheries Management Organisations (RFMOs) and related organisations. The aim of the site is to improve the effectiveness of the original IUU lists as a tool for a wide variety of stakeholders to better understand and combat illegal fishing and broader fisheries crime.
To date, the following regional organisations maintain or share lists of vessels that have been found to carry out or support IUU fishing within their own or adjacent convention areas and/or species of competence:
Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR)
Commission for the Conservation of Southern Bluefin Tuna (CCSBT)
General Fisheries Commission for the Mediterranean (GFCM)
Inter-American Tropical Tuna Commission (IATTC)
International Commission for the Conservation of Atlantic Tunas (ICCAT)
Indian Ocean Tuna Commission (IOTC)
Northwest Atlantic Fisheries Organisation (NAFO)
North East Atlantic Fisheries Commission (NEAFC)
North Pacific Fisheries Commission (NPFC)
South East Atlantic Fisheries Organisation (SEAFO)
South Pacific Regional Fisheries Management Organisation (SPRFMO)
Southern Indian Ocean Fisheries Agreement (SIOFA)
Western and Central Pacific Fisheries Commission (WCPFC)
The Combined IUU Fishing Vessel List merges all these sources into one list that provides a single reference point to identify whether a vessel is currently IUU listed. Vessels that have been IUU listed in the past and subsequently delisted (for example because of a change in ownership, or because the vessel is no longer in service) are also retained on the site, so that the site contains a full historic record of IUU listed fishing vessels.
Unlike the IUU lists published on individual RFMO websites, which may update vessel details infrequently or not at all, the Combined IUU Fishing Vessel List is kept up to date with the best available information regarding changes to vessel identity, flag state, ownership, location, and operations.
UN WOD 2024 will take us on a journey of discovery through the ocean's vastness, tapping into the wisdom and expertise of global policy-makers, scientists, managers, thought leaders, and artists to awaken new depths of understanding, compassion, collaboration and commitment for the ocean and all it sustains. The program will expand our perspectives and appreciation for our blue planet, build new foundations for our relationship to the ocean, and ignite a wave of action toward necessary change.
Donate to charity during this holiday seasonSERUDS INDIA
For people who have money and are philanthropic, there are infinite opportunities to gift a needy person or child a Merry Christmas. Even if you are living on a shoestring budget, you will be surprised at how much you can do.
Donate Us
https://serudsindia.org/how-to-donate-to-charity-during-this-holiday-season/
#charityforchildren, #donateforchildren, #donateclothesforchildren, #donatebooksforchildren, #donatetoysforchildren, #sponsorforchildren, #sponsorclothesforchildren, #sponsorbooksforchildren, #sponsortoysforchildren, #seruds, #kurnool
AHMR is an interdisciplinary peer-reviewed online journal created to encourage and facilitate the study of all aspects (socio-economic, political, legislative and developmental) of Human Mobility in Africa. Through the publication of original research, policy discussions and evidence research papers AHMR provides a comprehensive forum devoted exclusively to the analysis of contemporaneous trends, migration patterns and some of the most important migration-related issues.
Preliminary findings _OECD field visits to ten regions in the TSI EU mining r...OECDregions
Preliminary findings from OECD field visits for the project: Enhancing EU Mining Regional Ecosystems to Support the Green Transition and Secure Mineral Raw Materials Supply.
This report explores the significance of border towns and spaces for strengthening responses to young people on the move. In particular it explores the linkages of young people to local service centres with the aim of further developing service, protection, and support strategies for migrant children in border areas across the region. The report is based on a small-scale fieldwork study in the border towns of Chipata and Katete in Zambia conducted in July 2023. Border towns and spaces provide a rich source of information about issues related to the informal or irregular movement of young people across borders, including smuggling and trafficking. They can help build a picture of the nature and scope of the type of movement young migrants undertake and also the forms of protection available to them. Border towns and spaces also provide a lens through which we can better understand the vulnerabilities of young people on the move and, critically, the strategies they use to navigate challenges and access support.
The findings in this report highlight some of the key factors shaping the experiences and vulnerabilities of young people on the move – particularly their proximity to border spaces and how this affects the risks that they face. The report describes strategies that young people on the move employ to remain below the radar of visibility to state and non-state actors due to fear of arrest, detention, and deportation while also trying to keep themselves safe and access support in border towns. These strategies of (in)visibility provide a way to protect themselves yet at the same time also heighten some of the risks young people face as their vulnerabilities are not always recognised by those who could offer support.
In this report we show that the realities and challenges of life and migration in this region and in Zambia need to be better understood for support to be strengthened and tuned to meet the specific needs of young people on the move. This includes understanding the role of state and non-state stakeholders, the impact of laws and policies and, critically, the experiences of the young people themselves. We provide recommendations for immediate action, recommendations for programming to support young people on the move in the two towns that would reduce risk for young people in this area, and recommendations for longer term policy advocacy.
Milton Keynes Hospital Charity - A guide to leaving a gift in your Will
Telepharmacy
1. NEHA KANSWAMI
G.Pulla Reddy College of Pharmacy
Course : (Swayam) UGC MOOC;Academic Writing
Application number: fa8e0400f0af11e9b29fa7940f9b4a22
2. Telemedicine is the use of telecommunication and information technology to
provide clinical health care from a distance. It has been used to overcome distance
barriers and to improve access to medical services that would often not be consistently
available in distant rural communities.
The World Health Organization (WHO) defines Telemedicine as, “The delivery of
healthcare services, where distance is a critical factor, by all healthcare professionals
using information and communication technologies for the exchange of valid
information for diagnosis, treatment and prevention of disease and injuries, research
and evaluation and for the continuing education of healthcare providers, all in the
interests of advancing the health of individuals and their communities.”
WHAT IS TELEMEDICINE?
2CC BY-SA-NC
3. 3
Telepharmacy is delivery of pharmaceutical care via
telecommunications to patients in locations where they may not have direct
contact with pharmacist. It is an instance of wider phenomenon of telemedicine,
as implemented in the field of pharmacy.
• Telepharmacy services include drug therapy monitoring, patient counseling,
monitoring of formulary compliance with the aid of teleconferencing or
videoconferencing.
• Telepharmacy services can be delivered at retail pharmacy sites or through
hospitals, nursing homes or other medical care facilities.
TELEPHARMACY
CC BY-SA-NC
4. 4
In 2001, North Dakota became the first U.S. state to pass regulations
allowing retail pharmacies to operate without requiring a pharmacist to be
physically present. The next year, state agencies and grants established the
North Dakota Telepharmacy Project, which now supports more than fifty
remote retail and hospital pharmacy sites throughout North Dakota. In this
program, a licensed pharmacist at a central site communicates with remote
site pharmacy technicians and patients through videoconferencing.
Implementation
CC BY-SA-NC
5. How Does Telepharmacy Work?
5
Small pharmacies or clinics in remote, isolated areas are connected to a central pharmacy
through novel software, videophone systems, and automated dispensing machines.
Patients bring their prescriptions to the remote sites, which are staffed by either pharmacy
technicians or nurses.
The central pharmacist provides oversight via teleconferencing systems and processes the
prescription faxed from the rural site.
The pharmacist releases several items at the rural site, including the prescription label and
the prepackaged medication from the automated dispensing machine.
CC BY-SA-NC
6. STEPS INVOLVED:
6
Prescriptio
n arrives at
the
pharmacy.
The
prescriptio
n is filled.
The
pharmacist
verifies the
prescriptio
n.
Live video
patient
counseling
CC BY-SA-NC
7. 7
EVALUATION THE PRESCRIPTION:
CC BY-SA-NC
It starts when medication orders
from a physician in a rural
hospital are sent to an urban
hospital pharmacy via a scanning
device. Nursing staff also enter
the medication order into the
patient’s electronic medical
record.
8. 8
VERIFICATION:
CC BY-SA-NC
The urban hospital pharmacist
reviews the order in the medical
record system against the scanned
copy. This process is used both to
check the accuracy of the order
entry and also to check the
appropriateness of the order. In
order to do this, the pharmacist
must have access to the patient’s
complete medical record.
10. CC BY-SA-NC 10
RESTOCKING OFADM’S
The telepharmacy program
also allows the urban
pharmacist to oversee the
restocking of the automated
dispensing device, using a
specially mounted video
camera. The camera, on a
rolling cart, is positioned
next to the cabinet that needs
to be restocked. In this way,
the urban pharmacist can
actually see down into each
drawer as it is being filled.
11. Step-by-Step Guide to Creating a Successful Program
A. Starting A Telepharmacy
1.General principles & first point of contact
2.License Application (NCPDP National Council for Prescription Drug Programs and
DEA federal Drug Enforcement Administration
3.Assess the Need
4.Develop Community Partners
In determining the level of support for telepharmacy services and defining the scope
of services needed in the targeted community, feedback from the following project
partners may be beneficial:
Individual Patients
Senior Citizen Groups
Rural Health Clinic Personnel
Community Business leaders
Local Community Leaders
11CC BY-SA-NC
12. 12
Local Government Officials
Pharmacist Practicing in the area
State Board of Pharmacy Administrator
State Pharmaceutical Association
School of Pharmacy
5. Secure a Physical Location
a. Criteria to consider for location of retail telepharmacy
services:
Convenient Access for the Public
Proximity to other Health Clinic Facilities ,Proximity to
Nursing Homes
Leased after Development by Local
Lease space in an existing business.
Technology Transmission or Connectivity Capabilities in
the Community
CC BY-SA-NC
13. 13
b. Criteria to consider for starting hospital telepharmacy services
B. Planning Construction
1. Retail Telepharmacies
2. Information Technology Considerations
Installation of VPN (Virtual private network)-encrypts all information between
endpoints and protects private info.
3. Personnel Considerations
Pharmacy Technician
Licensed Pharmacist
Patient Considerations
CC BY-SA-NC
14. 1. Inpatient (remote order-entry
review)
2. Remote dispensing
(retail/outpatient/discharge)
3. IV admixture
4. Remote counseling
DIFFERENT TYPES OF TELEPHARMACY:
14CC BY-SA-NC
15. INPATIENT (REMOTE ORDER-ENTRY REVIEW):
Inpatient telepharmacy refers to a pharmacist at a remote location
performing remote order-entry services for an inpatient pharmacy at a hospital.
The remote pharmacist reviews medication orders before the hospital staff
administers the drugs to the patient.
REMOTE DISPENSING (RETAIL/OUTPATIENT/DISCHARGE):
A remote-dispensing site, or retail community telepharmacy, is a licensed brick-
and-mortar pharmacy staffed by a certified pharmacy technician. A pharmacist
supervises the technician, reviews prescriptions and performs his or her duties from
a remote location via technology.
15CC BY-SA-NC
16. 16
IV ADMIXTURE:
The joint commission on accreditation of healthcare organizations (jcaho)
defines iv admixture as, “the preparation of pharmaceutical product which
requires the measured addition of a medication to a 50 ml or greater bag or bottle
of intravenous fluid.” In layman's terms, iv admixture is the mixing of iv solution
administered to patients in a hospital setting.
REMOTE COUNSELING:
Remote-patient counseling equates to providing patient counseling via a live-
and-interactive video session, or by some means through telecommunications.
CC BY-SA-NC
18. 18
.
Traditional full
service pharmacy
Remote
consultation
sites
Hospital
telepharmacy
Automated
dispensing
machines(ADMs)
These telepharmacy sites
have complete drug
inventories that include
prescription and over the
counter medications
along with other-health-
and beauty aids and other
general merchandise
Prescriptions are
prepared at the central
pharmacy and are
delivered to the rural
sites.
Audio and video
computer links are used
to deliver patient
counseling and education
Hospital pharmacist in
urban medical center
reviews processes and
verifies the prescriptions
that are issued and
electronically sent from
rural hospitals.
Automated dispensing
machine (ADM) is used
to electronically release
the prepackaged
medication.
Pharmacist at a central
location upon receiving
drug order (electronically
or by fax) confirms the
patient profile, conducts
proper drug utilization
review, and finally
instructs the ADM to
release the medication
CC BY-SA-NC
23. 23
• One major benefit is that many areas especially the remote ones that have no
access to pharmaceutical care or pharmacist will enjoy the services due to the
introduction of these services. Telepharmacy is one way that many people
living in remote areas will enjoy especially if they are unable to get basic
experts in the pharmacy care thus reducing the cost of traveling to other places
for the same services. Patients are also counseled, and drug administering is
monitored from time to time.
CC BY-SA-NC
24. Disadvantages
24
1) Pharmacy regulation laws
2) Operational difficulties
3) More time, effort, and money
4) Security
5) Reluctance to use technology
6) Continuity of care
CC BY-SA-NC
25. Conclusion:
Rural residents and communities lack easy access to healthcare services often due to
geographical and demographical factors.
Telepharmacy holds significant promise as a technology to improve access to
pharmaceutical care for people living in rural and remote communities.
Telepharmacy is quickly becoming an integral part of modern pharmacy practice that has
the potential to provide quality pharmaceutical services, such as medication management,
dispensing, patient counseling, and drug information.
Inherent to the adoption of these practices are legal challenges and pitfalls that need to be
addressed. A well-developed system, however, can change the practice of pharmacy that is
beneficial to both the rural communities and the hospital or retail pharmacies that deliver
these services.
25CC BY-SA-NC
26. 26
References:
Angaran DM. Telemedicine and telepharmacy: current status and future implications.
Am J Health Syst Pharm. 1999;56(14):1405–1426. [PubMed]
National Advisory Committee on Rural Health and Human Services. 2006 Report to the
Secretary. Available at: http://ruralcommittee.hrsa.gov/nacpubs.htm. Accessed October 28,
2006.
North Dakota Telepharmacy Project. Telemedicine technical assistance documents: a
guide to getting started in telemedicine. Chapter 10. Available at:
http://telepharmacy.ndsu.nodak.edu/publications/TELEPHARMACY-TAD1.pdf. Accessed
October 10, 2006.
Peterson CD, Anderson HC. The North Dakota telepharmacy project: restoring and
retaining pharmacy services in rural communities. J Pharma Technol. 2004;20:28-39.
Retail Pharmacy Management. Telepharmacy making headway in remote states.
Available at: www.retailpharmacymgmt.com/indexpub.cfm?pubid=10. Accessed October
26, 2006.
CC BY-SA-NC
27. 27
Gulliford SM, Schneider JK, Jorgenson JA. Using telemedicine technology for
pharmaceutical services to ambulatory care patients. Am J Health Syst Pharm.
1998;55:1512-1515.
North Dakota Telepharmacy Project. Is a telepharmacy right for my
community? Available at:
http://telepharmacy.ndsu.nodak.edu/publications/communitymanual.htm.
Accessed October 9, 2006.
Integrated Pharmacy Research and Practice downloaded from
https://www.dovepress.com/ by 175.103.25.178 on 27-Oct-2016pharmacist’s
perspective on the clinical benefits and challenges.
CC BY-SA-NC
28. Acknowledgement
With great pleasure I pay deep sense of gratitude and heartfelt thanks to
team Academic Writing for their constant encouragement and support.
CC BY-SA-NC 28
29. Feed Back
A very good learning platform for students pursuing post graduation and
PhD.
Several software's and various tools were provided for practice which was
very helpful.
The Animations in the lectures are very helpful and very effective .The
notes provided is very good and clearly structured. Lectures are quite
interesting to listen to and very well delivered. Overall it was a good
learning experience.
CC BY-SA-NC 29